home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  November 21, 2019
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [Z] 529 active entries

Gastrex Canada

An SBO Company
Canada
Canada
Toll free: +011-778-554-6691

Phone: +011-778-554-6691
Fax: +011-604-941-9022

Description:

A proposal for strategic cooperation and investment with Universities & Colleges in the Negros Island region (NIR) of the Philippine Islands with outside investors involved with various technologies for their transfer for advancement, and to increase relevance and to extend their reach in science & technology, making them eco-culturally viable or achievable.

We encourage financially sound investment in partnership with Universities & Colleges as leading Universities in the Philippines have recently declared and established.

Our Project Portfolios for Research & Development:

1) Arctic-Alpen ICE (Immersion Cold Energy) MicroGen-Technology.

2) Micro-Syntheses of Drug VitD-Agonistes from Plant-based Lanosterol.

3) HQ Debuffered Silages using Micro-Zymogen Technology.

4) Micro-Consortia Using C-Sink Methano-Generation.

5) Micro-Tech with UreaZymogen Technology.

6) HIS Micro-Protect Yeast Technology with Silage in Organic Beef and Dairy. 

In all these projects metabolomics, proteomics and genomics with computational bioinformatics will require skills of: mathematicians, physicians, biochemists, microbiologists, agronomists and computer engineers to solve multi-disciplinary problems with probability of finding commercial success. 

The cell cycle and its division or termed mitogenic potential of the cell is regulated, in part, by 'ATP pools' and their feeding into the cell cycle from energy substrate (both protein, carbohydrate and fat) and by measures of interratio determine availability of either preformed amino acids (i. e. peptides/AA) or water soluble carbohydrates (e. g. FOS or fructan) and their balance of substrate with respect to ATP. In the case excess ATP is produced the ATP 'leaks' from the cells' entity. We will not quote specific studies here but supporting literature is available from 'Skye Blue' upon inquiry. Further investigation is required to document or prove operon control as regulated by substrate availability and to manipulate possibly further boosting the potential of microbial synthesis for microbial cell protein (MCP). The operons may present regulatory 'synergy' between substrates ' actions or may act to the 'core' of the cell given amino acids are fundmental to cell structure and mechanism. The extent to which both substrates are in tune with the 'core' cell cycling mechanism remains to be seen.

It was predicted that on two occasions at the masteral level that this 'nuclear' area of research in D. A. Flores' earlier investigation of amino acids and their utilization in regards to feed intake response (as readers may remember all nitrogen (N) balance or status data was 'redacted' due to wrongful reporting, the only revision of the two (2) papers both in reporting these fiindings) and duodenal amino acid flows as an indication of N status in sheep, that employment of PNA-B12 carriers to silence genes in this case to test putative families of transcription factors (TFs) (e. g. three may be involved each in 'core' metabolic amino acid supply and cell cycling or mitogenesis or water soluble carbohydrates (e. g. FOS or fructan) or all three applicable to both aspects of metabolic activity were and are now available for investigation of candidate factors in our studies.

The new field or frontier for D. A. Flores' earlier investigation into aminno acids and their utilization will encompass: biochemical cell signaling, neurotransmitter function, operon regulation, neurohormonal regulation, immunomodualtion, behavioral aspects in animal production including intake, metabolism in physiology, digestion and LBM/fat accretion or loss as a health & production parameter. 

 



Selected Categories:
Product Company   Service Company
Consulting
- General
Contract
- Services
Professional
- Communications

Last update of this entry: September 29, 2019

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2019 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.